anti-TP53TG5 antibody product blog
Tags: Antibody; Polyclonal Antibody; TP53TG5; anti-TP53TG5 antibody;
The TP53TG5 tp53tg5 (Catalog #MBS1495104) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The TP53TG5 Antibody, FITC conjugated reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s TP53TG5 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA). Researchers should empirically determine the suitability of the TP53TG5 tp53tg5 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.The TP53TG5 tp53tg5 product has the following accession number(s) (GI #7656983) (NCBI Accession #NP_055292.1) (Uniprot Accession #Q9Y2B4). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
May play a significant role in p53/TP53-mediating signaling pathway.
Storage Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Conjugate: FITC. Immunogen: Recombinant human TP53-target gene 5 protein
Santa Cruz Alternative: Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-85975. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing TP53TG5 are readily searchable from our website. Different antibodies against the same target such as TP53TG5 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.